COL10A1 and pancreatic adenocarcinoma: The results showed that the high expression of COL10A1 was accompanied by a decrease in the overall survival of PAAD patients (OS : HR = 2.44, 95% CI = 1.12–5.31, p = 0.004; Figure 3(c)).